C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression

Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles

(2017) Kyoung Mee Kim et al.   International Journal of Nanomedicine

Amygdalin Regulates Apoptosis and Adhesion in Hs578T Triple-Negative Breast Cancer Cells

(2016) Hye Min Lee et al.   Biomolecules & Therapeutics

From C-Reactive Protein to Interleukin-6 to Interleukin-1

(2016) Paul M Ridker   CIRCULATION RESEARCH

PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model

(2015) Hyun Sook Hwang et al.   BMB Reports

GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis

(2015) G Maric et al.   ONCOGENE

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells

(2015) Ying Qu et al.   PLoS One

Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition

(2014) Minsoo Koh et al.   INTERNATIONAL JOURNAL OF CANCER

βig-h3 Promotes Human Osteosarcoma Cells Metastasis by Interacting with Integrin α2β1 and Activating PI3K Signaling Pathway

(2014) Yun-Shan Guo et al.   PLoS One

The Binding of Monomeric C-Reactive Protein (mCRP) to Integrins αvβ3 and α4β1 Is Related to Its Pro-Inflammatory Action

(2014) Masaaki Fujita et al.   PLoS One

Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression

(2013) E-S Kim et al.   ONCOGENE

Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis

(2013) R A Bartolomé et al.   ONCOGENE

Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells

(2012) I Tsaur et al.   BRITISH JOURNAL OF CANCER

A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo

(2012) V. M. Golubovskaya et al.   CARCINOGENESIS

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

(2012) Otto Metzger-Filho et al.   JOURNAL OF CLINICAL ONCOLOGY

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma

(2011) A. J. Zurita et al.   ANNALS OF ONCOLOGY

Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-G q coupling

(2011) E.-S. Kim et al.   JOURNAL OF CELL SCIENCE

Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients

(2011) Praveen Ravishankaran et al.   World Journal of Surgical Oncology

The α2β1 integrin is a metastasis suppressor in mouse models and human cancer

(2010) Norma E. Ramirez et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular mechanisms of metastasis in breast cancer—clinical applications

(2010) Michal Mego et al.   Nature Reviews Clinical Oncology

Integrin  2 Mediates Selective Metastasis to the Liver

(2009) K. Yoshimura et al.   CANCER RESEARCH

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

(2009) Brandon L. Pierce et al.   JOURNAL OF CLINICAL ONCOLOGY

Focal Adhesion Kinase Versus p53: Apoptosis or Survival?

(2008) W. G. Cance et al.   Science Signaling